Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021

Effectively treating hepatitis C viral (HCV) infections prevents sequelae and onward transmission. In Germany, HCV drug prescriptions have declined since 2015. During the COVID-19 pandemic, lockdowns impacted the access to HCV care services and HCV treatment. We assessed if the COVID-19 pandemic fur...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Emily D., Dudareva, Sandra, Kollan, Christian, Mauss, Stefan, Wedemeyer, Heiner, Schmidt, Daniel, Zimmermann, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267983/
https://www.ncbi.nlm.nih.gov/pubmed/37325322
http://dx.doi.org/10.3389/fpubh.2023.1149694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267983/
https://www.ncbi.nlm.nih.gov/pubmed/37325322
http://dx.doi.org/10.3389/fpubh.2023.1149694

Ejemplares similares